BlueLinx (BXC)
(Delayed Data from NYSE)
$112.95 USD
-0.64 (-0.56%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $112.94 -0.01 (-0.01%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for BlueLinx Holdings Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3,136 | 4,450 | 4,277 | 3,097 | 2,637 |
Cost Of Goods | 2,609 | 3,617 | 3,499 | 2,620 | 2,280 |
Gross Profit | 527 | 833 | 778 | 478 | 357 |
Selling & Adminstrative & Depr. & Amort Expenses | 389 | 394 | 340 | 335 | 322 |
Income After Depreciation & Amortization | 138 | 439 | 438 | 142 | 35 |
Non-Operating Income | -33 | -2 | 1 | 0 | -3 |
Interest Expense | 24 | 42 | 46 | 47 | 54 |
Pretax Income | 82 | 395 | 394 | 95 | -22 |
Income Taxes | 33 | 99 | 98 | 14 | -4 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 49 | 296 | 296 | 81 | -18 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 49 | 296 | 296 | 81 | -18 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 168 | 464 | 464 | 171 | 65 |
Depreciation & Amortization (Cash Flow) | 29 | 25 | 26 | 29 | 30 |
Income After Depreciation & Amortization | 138 | 439 | 438 | 142 | 35 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 8.99 | 9.40 | 9.87 | 9.46 | 9.34 |
Diluted EPS Before Non-Recurring Items | 10.07 | 31.80 | 29.99 | 7.71 | -1.25 |
Diluted Net EPS (GAAP) | 5.39 | 31.51 | 29.99 | 8.55 | -1.89 |
Fiscal Year end for BlueLinx Holdings Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 712.53 | 809.98 | 815.97 | 797.90 |
Cost Of Goods | NA | 594.10 | 670.74 | 680.16 | 664.37 |
Gross Profit | NA | 118.43 | 139.25 | 135.80 | 133.54 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 91.24 | 99.59 | 96.71 | 101.02 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 27.19 | 39.66 | 39.09 | 32.52 |
Non-Operating Income | NA | -31.04 | -0.59 | -0.59 | -0.59 |
Interest Expense | NA | 4.17 | 5.58 | 6.31 | 7.69 |
Pretax Income | NA | -8.02 | 33.49 | 32.19 | 24.23 |
Income Taxes | NA | 10.10 | 9.10 | 7.72 | 6.42 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -18.12 | 24.38 | 24.47 | 17.81 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -18.12 | 24.38 | 24.47 | 17.81 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 8.76 | 8.97 | 9.06 | 9.16 |
Diluted EPS Before Non-Recurring Items | NA | 2.64 | 2.73 | 2.75 | 2.16 |
Diluted Net EPS (GAAP) | NA | -1.96 | 2.71 | 2.70 | 1.94 |